Novavax (NVAX) saw its stock price surge by 11.52% during Wednesday's intraday trading session, reflecting strong investor interest in the biotech company.
The rally was accompanied by unusually high call volume, with 15,177 calls traded—three times the expected volume—and implied volatility rising nearly 8 points to 71.12%. This bullish option activity suggests traders are betting on further upside for Novavax in the near term.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments